1:5 Stock Split: Chemicals & Pharma Stock Plunges 5% On Trading Ex-Split On March 11; Are You Eligible?

IOL Chemicals 1:5 Stock Split Record date today: IOL Chemicals and Pharmaceuticals Ltd shares opened in red on Tuesday as the stock began trading on an ex-split basis. The Indian pharma company shares were down 5% at Rs 65.6 per share on BSE at 10 am.

The IOL Chemicals and Pharmaceuticals board of directors approved a stock split in 1:5 and fixed the record date as March 11, 2025. The IOL Chemicals stock split will reduce the face value of each share from Rs 10 to Rs 2.

IOL Chemicals and Pharmaceutical will finalise shareholder eligibility for payouts and stock adjustments on Tuesday, March 11 after stock split.

IOL CP Record date today

The pharma API and speciality chemicals manufacturers fixed 11 March as the record date and its new ISIN will be effective from today.

"This is in continuation to our earlier letter dated 7 th February 2025 regarding intimation of Record Date of 11 th March 2025 for Sub-division/ split of existing Equity Shares of the Company from 1 (One) Equity Share having face value of Rs. 10/- (Rupees Ten Only) each, fully paid-up, into 5 (Five) Equity Shares having face value of Re. 2/- (Rupee Two Only) each, fully paid-up," the company said in its press release dated 5 March.

"In this regard, we wish to inform you that National Securities Depository Limited (NSDL) and Central Depository Services Limited (CDSL) have assigned a new ISIN i.e. INE485C01029 for equity shares of face value of Rs 2 each. The new ISIN will be effective from Tuesday, 11th March 2025 ("Record Date")," the press release added.

IOL Chemicals share price

IOL Chemicals and Pharmaceuticals shares opened at Rs 68.9 per share on BSE on Tuesday. The company scrip was down 5% at Rs 65.6 at 10 am.

IOL Chemicals and Pharmaceuticals Ltd share price closed nominally lower at Rs 345.55 per share on Monday with a market capitalisation of Rs 2,028.57 crore before stock split came into effect.

IOL Chemicals stock split: How will it benefit the company?

The stock split, approved by the board of directors in March, will help the company in improving its liquidity as they will be more affordable for investors for purchase. The move may lead to a wider investor participation and improved liquidity in the market.

Investors holding IOL Chemicals stocks on record date, i.e. today, will receive the new shares with revised face value in their demat accounts. The stock price will be adjusted based on the split ratio, ie 1:5.

IOL Chemicals stock split eligibility

To be eligible for IOL Chemicals stock split on the record date, investors must ensure that their shares are registered in their demat account before 11 March. Only investors with IOL Chemicals share before 11 March are identified as eligible shareholders for stock split.

IOL Chemicals and Pharmaceuticals declared stock split for the first time in December 2024 and the company shareholders approved the split via a postal ballot on 31 January 2025.

About IOL Chemicals and Pharmaceuticals Ltd

IOL Chemicals and Pharma is one of the leding pharmaceuticals (API) manufacturers in India which has a specialty in producing and supplying therapeutic drugs related to pain management, anticonvulsants, anti-diabetes, etc.

IOL Chemicals and Pharmaceuticals primarily manufactures and supplies APIs; Ibuprofen, Metformin, Fenofibrate, Clopidogrel, Lamotrigine, Pantoprazole, Paracetamol, etc. With an installed capacity of over 12,000 TPA, the company is known as the world's largest producer of Ibuprofen.